Bioreactor technology advances can offer seamless manufacturing scale-up and can reduce the timeline and cost of biologics production.
Melisa Carpio
Advertisement
Melisa Carpio is a global technology consultant for Cell Culture Technologies at Sartorius North America.
Articles by Melisa Carpio
Advertisement
Latest Updated Articles
Advertisement
Advertisement